Eric Alton, MD, led Monday’s Keynote Series session at the ATS 2025 International Conference, sharing breakthroughs and challenges of targeted gene therapies for cystic fibrosis and exploring subsequent applications for other respiratory diseases.

While their groundbreaking contributions to respiratory medicine were in the spotlight during the Respiratory Health Awards Ceremony on Sunday at ATS 2025 San Francisco, awardees also shared inspirational messages for career success and overcoming challenging times.

Yolanda Mageto, MD, MPH, ATSF, the featured speaker at Monday’s Women’s Forum during the ATS 2025 International Conference, shared valuable lessons she has accumulated throughout her esteemed career, along with her reflections on success, purpose, and the next generation of women leaders in medicine.

Researchers unveiled results from four impactful clinical trials for the first time during “Breaking News: 2025 Clinical Trial Results in Pulmonary Medicine” on Sunday at the ATS 2025 International Conference.

Raed A. Dweik, MD, MBA, ATSF, attended his first ATS International Conference as a fellow in Boston in 1994 and hasn’t missed one since. During Tuesday’s Plenary Session at ATS 2025 San Francisco, he will receive the presidential gavel from Irina Petrache, MD, ATSF. Dr. Dweik spoke with ATS Conference News about his vision for…

The Pediatric Core Curriculum will host its third and final session at ATS 2025 San Francisco on Wednesday, May 21, concluding the series’ exploration of current and emerging pediatric pulmonary testing methods. The closing day’s presentations will delve into vital considerations for ventilator diagnostics in the home and inpatient settings.

New ATS guidelines on treatment for community-acquired pneumonia will be revealed during the session, “ATS Guidelines: Controversies in the Management of CAP and ARDS,” on Tuesday, May 20. Session Co-Chair Ann L. Jennerich, MD, MS, ATSF, shared that the session would also include conversations about using neuromuscular blocking agents for acute respiratory distress syndrome.

On Tuesday, May 20, experts will debate whether clinical trials should reconsider standard practice and begin grouping bronchiectasis patients with and without cystic fibrosis during the Chair’s Symposium. Session Chairs Raksha Jain, MD, MSci, ATSF, and Jennifer Taylor-Cousar, MD, MSCS, ATSF, outlined considerations for the debate.

“Technological Advancements in Pediatric Pulmonology: Remote Data and Decision Support,” on Wednesday, May 21, will examine new technologies in pediatric pulmonology and how they might apply to other areas of respiratory health care, according to Sze Man Tse, MD, MPH, session co-chair.